In vitro and in vivo synergistic activity of colistin, rifampin, and amikacin against a multiresistant Pseudomonas aeruginosa isolate

被引：25

作者：

Tascini, C ^{[1
]}

Ferranti, S ^{[1
]}

Messina, F ^{[1
]}

Menichetti, F ^{[1
]}

机构：

[1] Azienda Osped Pisana, UO Malattie Infett, I-56100 Pisa, Italy

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2000年 / 6卷 / 12期

关键词：

D O I：

10.1046/j.1469-0691.2000.00169.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：690 / 691

页数：2

相关论文

共 9 条

[1] Hogg GM, 1998, J ANTIMICROB CHEMOTH, V42, P413
[2] Hu Fung-Rong, 1992, Journal of the Formosan Medical Association, V91, P190
[3] Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
Levin, AS
Barone, AA
Penço, J
Santos, MV
Marinho, IS
Arruda, EAG
Manrique, EI
Costa, SF
[J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) : 1008 - 1011
[4] Comparative in vitro autimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations
Marques, MB
Brookings, ES
Moser, SA
Sonke, PB
Waites, KB
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 881 - 885
[5] *NAT COMM CLIN LAB, 1998, M21A NCCLS
[6] *NAT COMM CLIN LAB, 1993, M100S5 NCCLS
[7] Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii -: J Antimicrob Chemother 1998; 42:270-271
Tascini, C
Menichetti, F
Bozza, S
Del Favero, A
Bistoni, F
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) : 270 - 271
[8] THORNSBERRY C, 1983, REV INFECT DIS, V5, pS412
[9] POLYCATIONS AS OUTER MEMBRANE-DISORGANIZING AGENTS
VAARA, M
VAARA, T
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (01) : 114 - 122